Israel Englander Avrobio, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.58 - $1.31 $3,509 - $7,926	6,051 Added 3.45%	181,590 $172,000
Q1 2023 May 15, 2023	SELL	$0.76 - $1.82 $389,990 - $933,925	-513,146 Reduced 74.51%	175,539 $176,000
Q4 2022 Feb 14, 2023	SELL	$0.64 - $0.91 $13,345 - $18,975	-20,852 Reduced 2.94%	688,685 $491,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $57,789 - $94,333	-84,985 Reduced 10.7%	709,537 $456,000
Q2 2022 Aug 15, 2022	BUY	$0.75 - $1.33 $202,562 - $359,210	270,083 Added 51.5%	794,522 $731,000
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $144,400 - $452,229	-111,938 Reduced 17.59%	524,439 $692,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $702,323 - $1.23 Million	-203,572 Reduced 24.24%	636,377 $2.45 Million
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $1.5 Million - $2.52 Million	271,626 Added 47.79%	839,949 $4.69 Million
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $923,301 - $1.48 Million	-117,768 Reduced 17.17%	568,323 $5.05 Million
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $2.19 Million - $4.01 Million	-207,773 Reduced 23.24%	686,091 $8.71 Million
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $2.38 Million - $3.18 Million	185,800 Added 26.24%	893,864 $12.5 Million
Q3 2020 Nov 16, 2020	BUY	$12.99 - $19.41 $2.2 Million - $3.28 Million	169,109 Added 31.38%	708,064 $9.22 Million
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $894,270 - $1.68 Million	73,361 Added 15.76%	538,955 $9.41 Million
Q1 2020 May 14, 2020	BUY	$10.08 - $27.21 $3.07 Million - $8.28 Million	304,213 Added 188.51%	465,594 $7.25 Million
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $2.11 Million - $3.53 Million	161,381 New	161,381 $3.25 Million
Q3 2019 Nov 14, 2019	SELL	$14.12 - $23.44 $423,741 - $703,434	-30,010 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$13.21 - $27.29 $5.24 Million - $10.8 Million	-396,973 Reduced 92.97%	30,010 $488,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $5.64 Million - $11.7 Million	426,983 New	426,983 $3.89 Million
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $5.41 Million - $11.5 Million	-350,877 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $3.77 Million - $7.38 Million	139,982 Added 66.38%	350,877 $18.2 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $5.92 Million - $6.58 Million	210,895 New	210,895 $6.02 Million

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account